Allergies represent a fascinating and clinically significant paradox of the human immune system. Coined by Austrian pediatrician Clemens von Pirquet in 1906, the term allergy describes an altered state of immune reactivity, a deviation from the norm that can result in either protective immunity or harmful tissue damage.
Today, allergies are understood as inappropriate, overactive immune responses to harmless environmental substances, known as allergens. Generally, Type I hypersensitivity reaction is driven by the production of Immunoglobulin E (IgE) antibodies that bind to and activate mast cells and basophils, triggering a cascade of inflammatory mediators such as histamine.
With allergic diseases reaching epidemic proportions globally, affecting nearly 30% of the population, understanding their mechanisms, triggers, and treatment is paramount for public health. This article explores the multifaceted world of allergies, from common types and symptoms to the latest innovations in diagnosis and therapy.
Origin of the word allergy
Clemens von Pirquet combined two Greek words, allos (meaning "other" or "strange") and ergon (meaning "work" or "reaction"), to describe this changed reactivity
Types of Allergies
Allergic reactions are typically classified based on the route of allergen exposure and the organ systems affected. The most common forms include:
Allergic Rhinitis (Hay Fever)
An allergic reaction to inhaled airborne allergens such as pollen, dust mites, or animal dander, causing inflammation of the nasal passages.
Allergic Asthma
An inflammatory condition of the airways often triggered by allergens like dust mites, pollen, and mould spores, leading to airway hyper-responsiveness and breathing difficulties.
Food Allergies
Result from an immune reaction to food proteins, most commonly from milk, eggs, peanuts, tree nuts, soy, and wheat. Reactions can range from mild hives to life-threatening anaphylaxis.
Drug Allergies
Adverse immunologic reactions to medications, with penicillin being a well-known example.
Atopic Dermatitis (Eczema)
An allergic skin condition characterised by red, itchy, and inflamed skin, often seen in early childhood and can be a precursor to the "atopic march".
Insect Venom Allergies
A severe allergy to stings from bees, wasps, or fire ants, which can cause serious systemic reactions.
Alpha-Gal Syndrome (AGS)
A unique food allergy to mammalian meat (e.g., beef, pork, lamb) caused by an immune response to a sugar molecule, galactose-alpha-1,3-galactose (alpha-gal). This allergy is unique in that it is triggered by a tick bite and often results in delayed symptoms. The Lone Star tick (Amblyomma americanum) of white-tailed deer is the main cause of α-gal allergy in the United States (Nature).
Sources of Allergens
Allergens can originate from a wide array of sources and enter the body through inhalation, ingestion, injection, or skin contact. Key sources include:
Airborne Allergens
Pollen from trees, grasses, and weeds; mould spores; house dust mite droppings; and animal dander from pets such as cats and dogs.
Food Allergens
Proteins from foods such as peanuts, tree nuts, milk, eggs, soy, wheat, fish, and shellfish.
Drugs and Medications
Drug allergies are immune system reactions, distinct from side effects. Common culprits include penicillin, sulfonamides, and NSAIDs like aspirin. Notably, up to 10% of people report a penicillin allergy. Still, over 90% are not truly allergic upon testing.
Insect Venom
Proteins in the venom of stinging insects such as bees, wasps, and hornets.
Contact Allergens
Substances like latex and certain chemicals, metals, or fragrances that cause allergic reactions upon skin contact.
Mammalian Meat
For individuals with AGS, the alpha-gal carbohydrate is found in the meat of non-primate mammals.
Typical Symptoms of Allergies
Allergic symptoms arise from the release of mediators like histamine, leukotrienes, and prostaglandins from activated mast cells and basophils. The clinical manifestation depends on the location of the reaction:
Respiratory Tract (Nose, Sinuses, Lungs)
- Sneezing, runny or stuffy nose (allergic rhinitis)
- Itchy, watery, red eyes (allergic conjunctivitis)
- Coughing, wheezing, and shortness of breath (asthma)
Skin
- Red, itchy, dry, and scaly patches (atopic dermatitis)
- Raised, itchy welts or hives (urticaria)
- Swelling in deeper skin layers (angioedema)
Gastrointestinal Tract
Nausea, vomiting, abdominal cramps, diarrhea (commonly seen in food allergies).
Systemic Severe Reactions (Anaphylaxis)
Anaphylaxis is a severe, life-threatening, and sudden allergic reaction that affects the whole body. Symptoms include difficulty breathing, swelling of the throat and tongue, a dangerous drop in blood pressure, dizziness, hives, and stomach cramps. It is a medical emergency requiring immediate treatment with epinephrine.
Why Are Some People Allergic to Safe Foods for Others?
The predisposition to develop allergies, including food allergies, is influenced by a complex interplay of genetics, environment, and immune system function.
Genetic Factors
Allergy has a strong heritable component. Individuals with a family history of allergic diseases are at a higher risk of developing atopic conditions, characterised by an increased tendency to produce IgE antibodies.
The Hygiene Hypothesis
The theory proposes that reduced exposure to microbes in early life, due to smaller families, cleaner environments, and antibiotic use, can shift the developing immune system toward a Th2-dominated profile. This Th2 type promotes allergic responses, whereas exposure to diverse microbes encourages the development of regulatory T cells that promote immune tolerance.
Immune Tolerance Failure
A healthy immune system usually develops oral tolerance, a state of unresponsiveness to harmless food proteins. In food allergy, this tolerance mechanism fails, and the body inappropriately mounts an IgE-mediated attack on ingested food proteins.
Epithelial Barrier Dysfunction
Evidence suggests that a compromised skin or gut barrier can allow allergens to penetrate and activate the immune system, triggering a cascade of allergic inflammation.
What is Alpha-Gal and How Does It Influence Allergic Reactions?
Alpha-gal (galactose-α-1,3-galactose) is an oligosaccharide (a carbohydrate molecule) found in the tissues of most mammals, with the notable exception of humans, apes, and Old-World monkeys. Its link to allergic reactions is unique and geographically variable:
Tick Bite Sensitisation
The primary cause of AGS is a prior bite from certain species of ticks, such as the Lone Star tick in the USA. The tick bite introduces alpha-gal from its saliva into the human host, sensitising their immune system to produce specific IgE antibodies against it.
Delayed-Onset Reaction
Unlike most food allergies, which trigger symptoms within minutes, the allergic reaction to mammalian meat in AGS is characteristically delayed by 2 to 6 hours after ingestion. This delayed response is thought to be related to the glycan's digestion and absorption in the gut via lipids.
Symptoms and Diagnosis
When a sensitised person eats mammalian meat (e.g., beef, pork), the ingested alpha-gal can cross-link IgE antibodies on mast cells hours later, causing symptoms ranging from hives and gastrointestinal distress to severe, life-threatening anaphylaxis.
Regional Variabilities of Allergy Occurrence
The prevalence and types of allergies vary significantly across different regions, influenced by a host of environmental and lifestyle factors.
Urban vs. Rural
Allergic diseases show a higher prevalence in cities compared to suburban and rural areas. However, the US inner cities remain an exception, with a high prevalence of allergies.
Alpha-Gal Syndrome
The distribution of AGS is strikingly regional, closely mirroring the geographic range of vector ticks. It is more common in parts of the United States, Europe, and Australia where specific tick species are prevalent.
Diet and Lifestyle
Differences in dietary habits, such as the increased intake of certain polyunsaturated fatty acids in a Western diet, and levels of microbial exposure from lifestyle and hygiene practices, contribute to regional differences.
Environmental Factors
Exposure to specific pollens and pollution levels, such as cigarette smoke, also contributes to the regional patterns of respiratory allergies and asthma.
What is the Treatment & Management?
Current management focuses on a three-pronged approach:
Allergen Avoidance
The first and most effective strategy is to identify and avoid the triggering allergen. This can include modifying the diet, limiting outdoor activity during high pollen seasons, or using HEPA filters to reduce dust mites.
Pharmacotherapy (Medications)
- Antihistamines: Help relieve mild symptoms like sneezing, runny nose, and hives by blocking histamine.
- Corticosteroids: Nasal sprays or inhalers reduce airway or nasal inflammation. Systemic corticosteroids are used for more severe asthma exacerbations.
- Decongestants: Used for temporary relief of nasal stuffiness.
- Epinephrine: The only treatment for anaphylaxis. It is a life-saving, self-administered injection for people at risk of severe reactions.
Allergen Immunotherapy (Desensitisation)
This treatment aims to make the immune system tolerant to an allergen over time.
- Allergy Shots (Subcutaneous Immunotherapy): Regular injections of increasing doses of the allergen are given. It is effective for hay fever, asthma, and insect venom allergies.
- Sublingual Immunotherapy (SLIT): Allergen tablets are dissolved under the tongue daily. Currently available for a few allergens, including grass pollen and dust mites.
Latest Innovations in Allergic Treatments
The field of allergy is advancing rapidly, with novel therapeutic strategies on the horizon.
Next-Generation Anti-IgE Antibodies
Researchers are engineering optimised versions of the anti-IgE antibody, omalizumab, with a higher binding affinity. These new variants, such as the C03 antibodies, can not only neutralise free IgE but also actively displace IgE already attached to allergic cells, potentially providing faster and more complete protection from anaphylaxis.
mRNA-Based Therapies
Inspired by the success of mRNA vaccines for infectious diseases, a new technology uses mRNA encapsulated in lipid nanoparticles to deliver allergens. This approach has shown promise in preclinical models of asthma, where it not only prevented but also treated allergic responses by shifting the immune system toward a protective Th1 response while reducing allergic Th2 inflammation.
IgE-Vaccination (Kinoid Technology)
A novel conjugate vaccine, IgE-kinoid, is being developed to induce long-term production of neutralising autoantibodies against IgE. In humanised mouse models, this vaccine provided long-lasting protection (up to 12 months) against severe anaphylaxis, offering a potential cost-effective, long-term therapeutic strategy for IgE-mediated diseases.
Conclusion
Allergies represent a significant and growing global health challenge, stemming from a complex dysregulation of the immune system. While the foundational principles of allergen avoidance and symptom-relief medications remain critical, the field is undergoing a paradigm shift.
From understanding the unique tick-driven origin of Alpha-Gal Syndrome to harnessing the power of precision medicine, advances are paving the way for more effective and durable solutions.
Cutting-edge innovations, including next-generation antibodies, mRNA-based therapies, and novel vaccines, hold the promise of moving beyond managing symptoms to fundamentally altering the course of allergic diseases, offering hope for millions worldwide.